Category: Prescription Drugs

Durbin proposes federal study into rising insulin costs

by Ryan Voyles | Nov 19, 2019 | Federal Government, Prescription Drugs, Top Stories | 0

The U.S. Department of Health and Human Services would have to investigate why the cost of insulin has risen and how it has impacted the overall cost of healthcare under a proposal by U.S. Sen. Dick Durbin, D-Ill.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

Pritzker pledges to sign plan to cap out-of-pocket insulin costs

by Ryan Voyles | Nov 15, 2019 | Legislature, Prescription Drugs, Top Stories | 0

Gov. JB Pritzker said Thursday he will sign a plan approved by the General Assembly to cap out-of-pocket costs of insulin for some insurance plans.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

House approves cap on out-of-pocket cost for insulin

by Ryan Voyles | Nov 14, 2019 | Legislature, Prescription Drugs, Top Stories | 0

The House signed off on legislation Wednesday aimed at decreasing the price tag of insulin for patients.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

House committee signs off on amended plan to cap out-of-pocket costs for insulin

by Tim Stumm | Nov 13, 2019 | Legislature, Prescription Drugs, Top Stories | 0

A House committee approved an amended version of a plan to cap the out-of-pocket costs for insulin Tuesday afternoon.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

Illinois to receive $242 million in drug settlement

by Ryan Voyles | Nov 1, 2019 | Medicaid/Medicare, Prescription Drugs, Top Stories | 0

Illinois will recover $242 million from settlements with more than a dozen drug companies over allegations they inflated the wholesale prices used to set rates for Medicaid reimbursements.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.